Cyprus vs Fiji: HIV/AIDS deaths averted by antiretroviral therapy
Cyprus
64 deaths
in 2021
Fiji
82.71 deaths
in 2024
Cyprus rank
131st
Fiji rank
128th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Cyprus
- Fiji
How they compare
Fiji currently reports 82.71 deaths against 64 deaths in Cyprus, a difference of 18.71 deaths.
That makes Fiji's figure about 1.3 times Cyprus's.
The two have swapped places 1 time across 32 shared years of data; in 1990 it was Fiji ahead.
Cyprus ranks 131st and Fiji ranks 128th of 157 countries.
Cyprus has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Cyprus | Fiji | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 11.5 deaths | 0.4499 deaths | 11.05 deaths | Cyprus |
| 2010s | 42.1 deaths | 13.52 deaths | 28.58 deaths | Cyprus |
| 2020s | 63.5 deaths | 43.38 deaths | 20.12 deaths | Cyprus |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Cyprus or Fiji?
- Fiji, at 82.71 deaths against 64 deaths in Cyprus as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Cyprus and Fiji?
- 18.71 deaths, with Fiji ahead.
- How many years of comparable data are there for Cyprus and Fiji?
- 32 years are reported by both, from 1990 to 2021.
- How do Cyprus and Fiji rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Cyprus ranks 131st and Fiji ranks 128th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.